If you share a couch and your life with a gray-muzzled dog, you’re probably cherishing all the time you have with your beloved canine companion. It’s only natural to wonder how many years you might have left together.
Yahoo news reports that for the first time, a prescription drug built specifically to stretch a dog’s lifespan is within sight of veterinary clinics.
Loyal, a San Francisco biotech company, is developing LOY-002, a once-daily tablet for dogs 10 and older who weigh at least 14 pounds. The company has already cleared two of the three major technical sections the FDA requires before it can grant conditional approval, which means the pill could be available as early as late 2026 or 2027.
The term “anti-aging pill” often implies freezing time, turning back the block, or even something cosmetic.
LOY-002 specifically targets the metabolic concept that aging is linked to lowered sensitivity to insulin (and other body wide changes) so the thought is that improving sensitivity to insulin, and decreasing high insulin blood levels, could potentially increase longevity.
